Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05105503 · ClinicalTrials.gov registry record

Dialysis Access Monitoring Using a Digital Stethoscope-Based Deep Learning System

A clinical trial of Dialysis; Complications and Dialysis Access Malfunction, sponsored by Eko Devices.

Completed
Registry status
22
Enrollment target
1
Study location

NCT05105503 is a study of Dialysis; Complications and Dialysis Access Malfunction that has completed, run by Eko Devices. The registered enrollment target is 22 participants, below the 99-participant average among 4 other Dialysis; Complications trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05105503, a study of Dialysis; Complications and Dialysis Access Malfunction, has completed, sponsored by Eko Devices.

COMPLETED
Registry status
22 participants
Enrollment target
1
Study location

Study Summary

This study will enroll end-stage renal disease (ESRD) patients on hemodialysis with a maturing arteriovenous fistula (AVF) for hemodialysis access. A study staff member will mark with indelible ink on each participant's skin the three sites on the upper extremity where the Eko CORE digital stethoscope will be used to take sound recordings. 9 recordings will be taken (3 at each site) once per week during weekly dialysis treatments.

Interventions

  • DEVICE Eko CORE Digital Stethoscope

Study Locations (1)

North Carolina

  • Carolina Dialysis - Carrboro - Carrboro

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2022-05-23
Est. Completion 2024-12-31

Sponsor

Eko Devices

16 total trials

What the Registry Record Tells You About NCT05105503

The ClinicalTrials.gov registry entry for NCT05105503 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 99-participant average among 4 other Dialysis; Complications trials with a reported enrollment target (78% lower). The listed sponsor is Eko Devices, which has 16 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Dialysis; Complications appearing as the primary indexed condition, and to 1 intervention - of which Eko CORE Digital Stethoscope is the first listed.

NCT05105503 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT05105503 about?

NCT05105503 is a clinical study titled "Dialysis Access Monitoring Using a Digital Stethoscope-Based Deep Learning System". This study will enroll end-stage renal disease (ESRD) patients on hemodialysis with a maturing arteriovenous fistula (AVF) for hemodialysis access. A study staff member will mark with indelible ink on each participant's skin the three sites on the upper extremity where the Eko CORE digital stethosco...

What is the current status of trial NCT05105503?

This trial is currently completed. The enrollment target is 22 participants. The study started on 2022-05-23. Estimated completion is 2024-12-31.

What conditions does trial NCT05105503 study?

This clinical trial studies the following conditions: Dialysis; Complications, Dialysis Access Malfunction.

What interventions are being tested in trial NCT05105503?

The interventions under investigation include: Eko CORE Digital Stethoscope (DEVICE).

Who is sponsoring clinical trial NCT05105503?

This trial is sponsored by Eko Devices, which has 16 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05105503 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dialysis; Complications

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.